AltPep
PrivateLast Round
Series B
Jun 22, 2023
Total Funding Raised
$120.45M
Company Overview
AltPep is a biotechnology company that operates a proprietary peptide-based platform designed to diagnose and neutralize toxic precursors to amyloid diseases, offering innovative solutions for early detection and treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AltPep Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
AltPep Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 22, 2023 | ||||
| Series B | Jul 26, 2022 | ||||
| Series A | Jan 14, 2021 |
Key People
Founding team and executive leadership
AltPep Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| Senator Investment Group | Series B |
| Alexandria Venture Investments | Series B, Series A |
| Matrix Capital Management | Series B, Series A |
| Partners Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
New preclinical data for SOBIN-AD showed improved behavior in disease models.
- Dec 1, 2025
Presented at the CTAD 2025 conference on December 1, 2025.
AltPep Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AltPep's valuation, stock price, and market status.